Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology
Authors
Keywords
-
Journal
Internal and Emergency Medicine
Volume 7, Issue 2, Pages 113-131
Publisher
Springer Nature
Online
2011-12-12
DOI
10.1007/s11739-011-0744-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2012) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
- (2011) HG Laverty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Treatment-Related Mortality With Bevacizumab in Cancer Patients
- (2011) Vishal Ranpura et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
- (2011) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
- (2011) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
- (2011) Carlo Gambacorti-Passerini et al. JNCI-Journal of the National Cancer Institute
- Severe Peripheral Arterial Disease During Nilotinib Therapy
- (2011) P. Le Coutre et al. JNCI-Journal of the National Cancer Institute
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) V. Ranpura et al. AMERICAN JOURNAL OF HYPERTENSION
- Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
- (2010) F. A. B. Schutz et al. ANNALS OF ONCOLOGY
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- Trastuzumab-Related Cardiotoxicity Following Anthracycline-Based Adjuvant Chemotherapy: How Worried Should We Be?
- (2010) Patrick G. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials
- (2010) Stuart D. Russell et al. JOURNAL OF CLINICAL ONCOLOGY
- Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction
- (2010) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Three-Dimensional Echocardiography in Breast Cancer: Comparison With Two-Dimensional Echocardiography, Multiple-Gated Acquisition Scans, and Cardiac Magnetic Resonance Imaging
- (2010) Jonathan Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials
- (2010) Bostjan Seruga et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies
- (2010) Geoffrey J. Yoon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline-Induced Cardiomyopathy
- (2010) Daniela Cardinale et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
- (2010) Zahra Raisi Estabragh et al. LEUKEMIA RESEARCH
- Management of Trastuzumab-Related Cardiac Dysfunction
- (2010) Joseph R. Carver PROGRESS IN CARDIOVASCULAR DISEASES
- Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
- (2010) Daniela Cardinale et al. PROGRESS IN CARDIOVASCULAR DISEASES
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Management of hypertension in angiogenesis inhibitor-treated patients
- (2009) H. Izzedine et al. ANNALS OF ONCOLOGY
- Adjuvant targeted therapy in early breast cancer
- (2009) John Mackey et al. CANCER
- VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
- (2009) Hassane Izzedine et al. EUROPEAN JOURNAL OF CANCER
- Accelerated Approval of Cancer Drugs: Improved Access to Therapeutic Breakthroughs or Early Release of Unsafe and Ineffective Drugs?
- (2009) Elizabeth A. Richey et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- (2009) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents
- (2009) Maurizio Zangari et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Cardiovascular toxicity caused by cancer treatment: strategies for early detection
- (2009) Renske Altena et al. LANCET ONCOLOGY
- Adverse effects of anticancer agents that target the VEGF pathway
- (2009) Helen X. Chen et al. Nature Reviews Clinical Oncology
- Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
- (2009) Emanuel Raschi et al. PHARMACOLOGY & THERAPEUTICS
- Selective antagonism of anticancer drugs for side-effect removal
- (2009) Ariel Fernández et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
- (2008) Xiaolei Zhu et al. ACTA ONCOLOGICA
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Cardiotoxicity Profile of Trastuzumab
- (2008) Steven M Ewer et al. DRUG SAFETY
- Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
- (2008) Shobha Rani Nalluri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity
- (2008) Nilofer S. Azad et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?
- (2008) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
- (2008) Shenhong Wu et al. LANCET ONCOLOGY
- An evaluation of the cardiotoxicity of imatinib mesylate
- (2008) Antonio Luiz Ribeiro et al. LEUKEMIA RESEARCH
- The hERG K+ channel: target and antitarget strategies in drug development
- (2008) Emanuel Raschi et al. PHARMACOLOGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More